证券日报网讯 东土科技11月18日在互动平台回答投资者提问时表示，股价波动受多种因素影响，公司 当前经营秩序正常，不存在应披露而未披露的重大信息。公司重视市值管理维护，将通过多种方式与投 资者保持沟通，积极向市场传递公司的价值。当前，公司处于业务结构调整的窗口期，并已显现成效， 今年智能控制器业务在半导体领域已取得规模化订单。截至三季度，智能控制器、工业操作系统及相关 软件服务订单金额分别增长87.55%、13.63%。收入方面，智能控制器、工业操作系统及软件服务较去 年同期分别增长16.94%、12.85%。公司将坚持长期可持续发展战略，努力提升整体价值及核心竞争 力。 （编辑 王雪儿） ...

格隆汇11月18日丨东土科技(300353.SZ)在投资者互动平台表示，公司重视市值管理维护，将通过多种 方式与投资者保持沟通，积极向市场传递公司的价值。当前，公司处于业务结构调整的窗口期，并已显 现成效，今年智能控制器业务在半导体领域已取得规模化订单。截至三季度，智能控制器、工业操作系 统及相关软件服务订单金额分别增长87.55%、13.63%。收入方面，智能控制器、工业操作系统及软件 服务较去年同期分别增长16.94%、12.85%。公司将坚持长期可持续发展战略，努力提升整体价值及核 心竞争力。 ...

Group 1 - The core viewpoint of the news is that Dongtu Technology's stock has experienced fluctuations, with a year-to-date increase of 84.67% but a recent decline in the last five trading days by 3.64% [1] - As of November 14, Dongtu Technology's stock price is 21.20 yuan per share, with a market capitalization of 13.036 billion yuan [1] - The company has seen a net outflow of main funds amounting to 16.6873 million yuan, with significant selling pressure observed [1] Group 2 - Dongtu Technology, established on March 27, 2000, specializes in the research, production, and sales of hardware devices in the industrial control network field [2] - The company's main business revenue composition includes 68.97% from industrial network communication, 20.05% from intelligent controllers and solutions, and 10.98% from industrial operating systems and related software services [2] - As of September 30, the number of shareholders is 58,700, a decrease of 9.62% from the previous period, while the average circulating shares per person increased by 10.88% [2] Group 3 - Dongtu Technology has distributed a total of 107 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]

Core Viewpoint - Dongtu Technology (300353) has clarified its main business segments, which include industrial network communication, industrial operating systems and related software services, and intelligent controllers and solutions [1] Group 1 - The company operates in three primary business areas: industrial network communication, industrial operating systems and related software services, and intelligent controllers and solutions [1]

Core Viewpoint - Dongtu Technology's main business consists of three parts: industrial network communication, industrial operating systems and related software services, and intelligent controllers and solutions. The company does not engage in memristor neuromorphic chips [1] Group 1 - The company focuses on industrial network communication as one of its primary business segments [1] - The second segment involves industrial operating systems and related software services [1] - The third segment includes intelligent controllers and solutions [1]

Core Viewpoint - Dongtu Technology (300353.SZ) clarifies its main business segments, which do not include memristor neuromorphic chips [1] Group 1 - The company's main business consists of three parts: industrial network communication, industrial operating systems and related software services, and intelligent controllers and solutions [1]

Company Overview - Beijing Eastcom Technology Co., Ltd. is located in Shijingshan District, Beijing, and was established on March 27, 2000. The company was listed on September 27, 2012. Its main business involves the research, production, and sales of hardware devices in the industrial control network field, providing solutions for information transmission in industrial control systems [2]. Business Segmentation - The revenue composition of Eastcom Technology is as follows: Industrial network communication accounts for 68.97%, smart controllers and solutions for 20.05%, and industrial operating systems and related software services for 10.98% [2]. Market Performance - As of November 11, Eastcom Technology's stock price decreased by 2.02%, trading at 21.85 CNY per share, with a total market capitalization of 13.435 billion CNY. The stock has increased by 90.33% year-to-date but has seen a decline of 7.14% over the last five trading days and 14.72% over the last twenty days [1]. Capital Flow - In terms of capital flow, there was a net outflow of 26.42 million CNY from main funds, with large orders buying 40.32 million CNY (22.20% of total) and selling 54.13 million CNY (29.80% of total) [1]. Shareholder Information - As of September 30, the number of shareholders for Eastcom Technology was 58,700, a decrease of 9.62% from the previous period. The average number of circulating shares per person increased by 10.88% to 9,177 shares [2]. Financial Performance - For the period from January to September 2025, Eastcom Technology reported a revenue of 501 million CNY, a year-on-year decrease of 11.72%. The net profit attributable to the parent company was -148 million CNY, showing a year-on-year increase of 1.32% [2]. Dividend Information - Since its A-share listing, Eastcom Technology has distributed a total of 107 million CNY in dividends, with no dividends paid in the last three years [3].

Core Viewpoint - Dongtu Technology (300353.SZ) has resumed trading with a 3.83% increase in stock price to 25.20 yuan following the announcement of a plan to acquire 100% of Beijing Gaoweike Electric Technology Co., Ltd. through a combination of share issuance and cash payment [1][3]. Group 1: Acquisition Details - The acquisition involves purchasing 100% of Gaoweike's shares from 43 transaction parties, including Zhang Xun and Liu Xinping [1]. - The share issuance price is set at 18.56 yuan per share, which is not less than 80% of the average stock price over the previous 120 trading days [1]. - The final transaction price will be based on an evaluation report from a qualified appraisal agency, and the company will disclose this in the restructuring report [2][3]. Group 2: Financial Performance of Gaoweike - Gaoweike's revenue for 2024 is projected to grow by 2.76% year-on-year, but its net profit is expected to decline by 76.85% [4]. - The revenue figures for Gaoweike are 1.462 billion yuan for 2023, 1.502 billion yuan for 2024, and 1.007 billion yuan for the first nine months of 2025 [4][6]. Group 3: Financial Performance of Dongtu Technology - Dongtu Technology reported a revenue decline of 11.72% year-on-year for the first three quarters of 2025, totaling 501 million yuan, with a net loss of 148 million yuan [7]. - For the year 2024, the company achieved a revenue of 1.029 billion yuan, down 11.52% from the previous year, and a net profit of 39 million yuan, a decrease of 85.16% [8]. Group 4: Strategic Implications of the Acquisition - The acquisition is expected to enhance Dongtu Technology's capabilities in industrial artificial intelligence and smart control products by leveraging Gaoweike's industry experience and market channels [7]. - The integration aims to upgrade Dongtu Technology's offerings from product provision to comprehensive solutions and systematic services, thereby improving overall market competitiveness [7].

Group 1: Core Views - Multiple A-shares are set to resume trading, including Dongtu Technology and Weigao Blood Purification, following significant asset restructuring announcements [1][5] - Dongtu Technology plans to acquire 100% of Gaoweike, with the transaction expected to meet the criteria for a major asset restructuring [2][4] - Weigao Blood Purification intends to purchase 100% of Weigao Puri, also anticipated to constitute a major asset restructuring [5][6] Group 2: Dongtu Technology - Dongtu Technology will issue shares and pay cash to acquire Gaoweike, which will become a wholly-owned subsidiary post-transaction [2] - The share issuance price is set at 18.56 yuan per share, representing 80% of the average trading price over the previous 120 trading days [2] - The acquisition aims to enhance Dongtu's capabilities in providing comprehensive solutions and improve its market competitiveness [4] Group 3: Gaoweike Overview - Gaoweike, established in 2001, specializes in industrial automation and control systems, serving various manufacturing sectors [3] - The company has developed core products in motion control, including PLCs and servo systems, and has a broad customer base across China [3] Group 4: Weigao Blood Purification - Weigao Blood Purification's acquisition of Weigao Puri will expand its product line into pre-filled drug delivery systems and automatic safety delivery systems [7] - The company reported a total revenue of 2.736 billion yuan for the first three quarters of the year, reflecting a year-on-year growth of 3.45% [7]

Core Viewpoint - Multiple A-shares are set to resume trading, with significant asset restructuring announcements from Dongtu Technology and Weigao Blood Purification [1][6] Group 1: Dongtu Technology - Dongtu Technology plans to acquire 100% of Gaoweike through a combination of issuing shares and cash payments, with the stock resuming trading on November 3 [2] - The acquisition is expected to meet the criteria for a major asset restructuring, with the share price set at 18.56 yuan per share, which is 80% of the average trading price over the last 120 trading days [2] - Gaoweike, established in 2001, specializes in industrial automation and control systems, serving various sectors including new energy batteries and consumer electronics [3] - The acquisition aims to enhance Dongtu Technology's capabilities in providing comprehensive solutions and improve its competitiveness in the market [4] - In the first three quarters of 2025, Dongtu Technology reported a revenue of 500 million yuan, a year-on-year decrease of 11.72%, primarily due to a strategic shift in business structure [4] - New business segments, including smart controllers and industrial operating systems, showed significant growth, with order amounts increasing by 87.55% and 13.63% respectively [4] - Dongtu Technology is also strategically investing in the embodied robotics sector, indicating a broader focus on technological advancements [5] Group 2: Weigao Blood Purification - Weigao Blood Purification intends to acquire 100% of Weigao Puri through a share issuance, with the stock also resuming trading on November 3 [6] - The acquisition is anticipated to constitute a major asset restructuring, with the valuation and transaction price yet to be determined [6] - Weigao Puri, founded in 2005, is a leading manufacturer of pre-filled syringes, holding over 50% market share in China and ranking among the top five globally [6][7] - Post-acquisition, Weigao Blood Purification will diversify its business to include the development and production of medical packaging products, enhancing its resilience and growth potential [7] - For the first three quarters of this year, Weigao Blood Purification reported total revenue of 2.736 billion yuan, a year-on-year increase of 3.45%, with a net profit of 341 million yuan, up 7.92% [7]